Eversept Partners »

Ceribell shares owned by Eversept Partners

Quarter-by-quarter ownership of Ceribell (CBLL) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Ceribell

Tip: Access up to 7 years of quarterly data

All positions including Ceribell held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ceribell by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $196k 17k 11.49

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Uniqure Nv SHS (QURE)
Hca Holdings (HCA)
Miragen Therapeutics (VRDN)
Zimvie (ZIMV)
Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals (IONS)
PerkinElmer (RVTY)
Travere Therapeutics (TVTX)

View all positions for Eversept Partners

Top funds holding Ceribell

FMR
Tpg Gp A
Red Tree Management
BlackRock
Vanguard Group
Yu Fan
ABG-WTT Global Life Science Capital Partners GP
TimesSquare Capital Management
Federated Investors
Millennium Management
Geode Capital Management
Massachusetts Financial Services
Franklin Resources
CenterBook Partners
Redmile Group

View all funds holding Ceribell